Deep brain stimulation in posterior subthalamic area for Holmes tremor: Case reports with review of the literature
- PMID: 37034086
- PMCID: PMC10076748
- DOI: 10.3389/fneur.2023.1139477
Deep brain stimulation in posterior subthalamic area for Holmes tremor: Case reports with review of the literature
Abstract
Background: Holmes tremor (HT) is a refractory tremor associated with cortico-basal ganglia loops and cerebellothalamic tract abnormalities. Various drug treatments have been attempted; however, no treatment method has yet been established. Historically, thalamic deep brain stimulation (DBS) has been performed in medically refractory cases. Recently, the posterior subthalamic area (PSA) has been used for HT. Here, we report cases of HT and review the effectiveness and safety of PSA-DBS for HT.
Cases: We conducted a retrospective chart review of two patients with HT who underwent PSA-DBS. Improvement in tremors was observed 1 year after surgery without apparent complications.
Literature review: We identified 12 patients who underwent PSA-DBS for HT, including our cases. In six patients, PSA was targeted alone; for the rest, the ventralis intermediate nucleus (Vim) of the thalamus and PSA were simultaneously targeted. The Fahn-Tolosa-Marin Tremor Rating Scale improvement rates were 56.8% (range, 33.9-82.1%; n = 6) and 77.8% (range, 42.6-100%; n = 5) for the PSA-DBS and PSA+Vim-DBS, respectively.
Conclusion: Reasonable improvements in HT were observed after PSA-DBS. PSA might be an appropriate target for improving the symptoms of HT. Long-term observations, accumulation of cases, and randomized studies are required in future.
Keywords: Holmes tremor (HT); cerebellothalamic tract; cortico-basal ganglia loops; deep brain stimulation; posterior subthalamic area.
Copyright © 2023 Kamo, Oyama, Ito, Iwamuro, Umemura and Hattori.
Conflict of interest statement
GO has received speaker honoraria from Medtronic, Boston Scientific, Otsuka Pharmaceutical Co. Ltd., Sumitomo Dainippon Pharma Co. Ltd., Eisai Co., Ltd., Takeda Pharmaceutical Company Ltd., Kyowa Hakko Kirin Co. Ltd., and AbbVie GK. The Department of Research and Therapeutics for Movement Disorders, Juntendo University Graduate School of Medicine is an endowment department supported by an unrestricted grant from Medtronic and Boston Scientific. The remaining authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Figures
References
-
- Holmes G. On certain tremors in organic cerebral lesions. Brain. (1904) 27:327–75. 10.1093/brain/27.3.327 - DOI
Publication types
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous
